|
|
| Small Stocks, Big Money™ |
| Weekly Newsletter |
|
|
|
|
|
|
|
New Era Energy Locks In $115M Equity Boost and Strategic Financing to Accelerate 1GW Texas AI Data Center Campus
New Era Energy & Digital (Nasdaq: NUAI) strengthens its balance sheet with approximately $115M in equity proceeds, a $290M credit facility (including a $20M initial draw), and strategic backing from Macquarie, creating a clear capital runway for its flagship Texas Critical Data Centers project. With capacity planned to exceed 1GW and rising demand for AI infrastructure, the funding positions the company to rapidly advance multi-phase development and commercialization in the Permian Basin.
|
|
|
|
XTI Aerospace Surpasses $121M Pro Forma Revenue in 2025 and Targets $160M+ in 2026 on Drone Platform Expansion
XTI Aerospace (Nasdaq: XTIA) delivered $121.6M in pro forma full-year revenue in 2025 following its transformative Drone Nerds acquisition, establishing a scaled, data-driven drone and unmanned systems platform with expanding enterprise and defense opportunities . With fresh capital, strategic partnerships, and a streamlined focus, the company is guiding to $160M+ in 2026 revenue as it accelerates growth across its commercial, manufacturing, and autonomous defense segments.
|
|
|
|
|
Sharon AI Secures $74M from TCDC Stake Sale, Providing Non-Dilutive Capital to Accelerate AI Infrastructure Expansion
SharonAI Holdings (Nasdaq: SHAZ) realizes $74M in total proceeds—exceeding expectations—from the accelerated monetization of its 50% stake in Texas Critical Data Centers, including early redemption of a $50M note and additional equity upside from New Era Energy & Digital (Nasdaq: NUAI). The strengthened balance sheet and non-dilutive capital infusion position the company to rapidly scale sovereign AI and GPU cloud infrastructure across the high-growth Asia-Pacific market.
|
|
|
|
|
|
|
First Phosphate Lands Potential €170M AAA-Backed Financing to Advance Quebec Phosphate Project
First Phosphate Corp. (OTCQX: FRSPF) (CSE: PHOS) secures a major financing milestone with a €170M letter of intent from Denmark’s export credit agency, providing AAA-backed support for equipment and services tied to its high-purity igneous phosphate project in Quebec. The backing strengthens the company’s pathway to building a vertically integrated North American LFP battery supply chain targeting high-growth markets including energy storage, AI data centers, and electrification.
|
|
|
|
|
ASP Isotopes Targets $300M+ EBITDA with 2026 Commercial Launch Across High-Growth Isotope Markets
ASP Isotopes (Nasdaq: ASPI) is projecting a breakout year with first commercial shipments expected across multiple isotopes in 2026 and helium production ramping to nameplate capacity by Q3, supported by a robust $333M cash position . With expanding traction in nuclear medicine, semiconductors, and energy—and a long-term EBITDA target exceeding $300M—the company is positioning itself at the center of critical materials powering AI, quantum computing, and advanced healthcare.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Bimergen Energy (NYSE American: BESS) & Blue Gold Limited (NASDAQ: BGL)
|
|
|
|
|
|
|
|---|
|
|
|
Lantern Pharma (NASDAQ: LTRN) is a clinical-stage biopharmaceutical company using artificial intelligence to discover and develop precision oncology therapies. Its lead asset, LP-300, is currently in a Phase 2 clinical trial targeting never-smoker non-small cell lung cancer (NSCLC), a patient population with no FDA-approved therapy specifically designed for them. On March 31, 2026, Lake Street Capital Markets reaffirmed a Buy rating and $25 price target on Lantern Pharma (NASDAQ: LTRN), implying upside of more than 1,400% from current levels. The near-term catalyst is a Type C meeting with the FDA scheduled for May 14, 2026.
OBOOK Holdings, Inc. (Nasdaq: OWLS) is rapidly positioning OwlPay as a next-generation cross-border payments backbone, leveraging stablecoin rails to deliver near-instant settlement at dramatically lower costs—addressing a global market projected to reach $320 trillion by 2032. With expanding regulatory licenses, major partnerships like Visa Direct, and projected revenue growth accelerating toward $100M+, the company is converting its compliance moat into high-margin, recurring infrastructure revenue.
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases and advanced liver disease. Its lead asset, bezisterim (NE3107), is an orally available small molecule targeting neuroinflammation and insulin resistance, which are two of the principal biological drivers behind Parkinson's disease (PD), Alzheimer's disease (AD), and Long COVID. The company received a buy rating and $6 price target from Brookline Capital Markets in March 2025.
|
|
| Unlock Smarter Investing with RedChat |
 |
| Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market. |
| Access RedChat now, free of charge. |
|
|
|
|
Recent Research Coverage Updates
| Company |
Rating |
Price Target |
Firm |
Report Date |
| First Phosphate (OTCQX: FRSPF) | Buy | $1.65 | Noble Capital | April 14, 2026 |
| Gorilla Technology (Nasdaq: GRRR) | Buy | $39 | AGP | March 3, 2026 |
| The Metals Company (Nasdaq: TMC) | Buy | $11 | Wedbush | February 22, 2026 |
| The Metals Company (Nasdaq: TMC) | Buy | $9 | Cantor Fitzgerald | February 22, 2026 |
| Alliance Entertainment (Nasdaq: AENT) | Buy | $9 | Noble Capital | February 13, 2026 |
| Alliance Entertainment (Nasdaq: AENT) | Buy | $8 | Maxim | February 13, 2026 |
| XTI Aerospace (Nasdaq: XTIA) | Buy | $3 | Maxim | February 6, 2026 |
| New Horizon Aircraft (Nasdaq: HOVR) | Buy | $18 | Jones Trading | February 2, 2026 |
| Sixty Degrees Pharmaceuticals (Nasdaq: SXTP) | Buy | $24 | HC Wainwright | February 2, 2026 |
| New Horizon Aircraft (Nasdaq: HOVR) | Buy | $18 | Jones Trading | February 2, 2026 |
| Lantern Pharma (Nasdaq: LTRN) | Buy | $28 | Rodman & Renshaw | February 1, 2026 |
| Off The Hook (NYSE American: OTH) | Buy | $10 | ThinkEquity | January 19, 2026 |
| Enlivex Therapeutics (Nasdaq: ENLV) | Buy | $13 | HC Wainwright | January 13, 2026 |
| NioCorp Developments (Nasdaq: NB) | Buy | $8.7 | Freedom Capital Markets | January 7, 2026 |
|
|
|
|
 |
| Small Stocks, Big Money™ Podcast |
| The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else. |
| Available on: |
|
|
|
|
|
|
Upcoming Events
|
|
|
Nexalin Technology (NASDAQ: NXL)
4:15pm Eastern
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
|
|
|
|
Blue Gold Limited (NASDAQ: BGL)
11:00am Eastern
Blue Gold Limited is a vertically integrated gold fintech company developing what it believes will be the world’s first global, gold-backed digital currency ecosystem.
|
|
|
|
Archived Events
|
|
|
Biotech Resurgence: Platforms and Pipelines of Today’s Innovators
9:30am Eastern
RedChip’s virtual investor conference, Biotech Resurgence: Platforms and Pipelines of Today’s Innovators, delivers direct access to publicly traded innovators across biopharma, medtech, diagnostics, and digital health.
|
|
|
|
Quote of the Week
|
“ You can be happy with the companies you own, but may not be happy with their stock performance. If you know what you're investing in and are patient, you'll have your day when the market recognizes the value, but that may not be today or tomorrow.” |
|
|
— Byron Roth, ROTH Capital |
|
|
|
|
Order “Small Stocks, Big Money™” Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Some important things to remember when investing.
|
|
|
|
|
|
Copyright © 2026 Redchip Companies, Inc. |
|
|
{{ site_settings.company_name }} {{ site_settings.company_street_address_1 }} {{ site_settings.company_street_address_2 }} {{ site_settings.company_city }} {{ site_settings.company_state }} {{ site_settings.company_zip }} {{ site_settings.company_country }}
|
|
|
|
|
You are receiving this email because you have subscribed to receive updates from us. Should you wish to cancel your subscription, please click here to manage preferences. |
|
|
|
|
